Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

BACKGROUND: Healthcare decision makers need to make trade-offs between different elements of value of new treatments. Multicriteria decision analysis (MCDA) provides a framework that can help decision makers to understand stakeholders’ preferences and be explicit about the trade-offs that are being...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmacoecon Open
Egile Nagusiak: Garau, Martina, Hampson, Grace, Devlin, Nancy, Mazzanti, Nicola Amedeo, Profico, Antonio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2017
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5972119/
https://ncbi.nlm.nih.gov/pubmed/29623625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41669-017-0048-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak